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Abstract: As reported in our previous papers, a series of quinoxaline-2-carboxamide  
1,4-di-N-oxide derivatives were synthesized and studied as anti-tuberculosis agents. Here, 
the capability of the shake-flask method was studied and the retention time (expressed as 
log K) of 20 compounds were determined by RP-HPLC analysis. We found that the 
prediction of log P by the RP-HPLC analysis can result in a high accuracy and can replace 
the shake-flask method avoiding the experimental problems presented by quinoxaline  
di-N-oxides. The studied compounds were subjected to the ALOGPS module with the aim 
of comparing experimental log Po/w values and predicted data. Moreover, a preliminary  
in silico screening of the QSAR relationship was made confirming the influence of 
reduction peak potential, lipophilicity, H-bond donor capacity and molecular dimension 
descriptors on anti-tuberculosis activity. 
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1. Introduction 
Quinoxaline derivatives are a class of compounds that show very interesting biological properties 
and, therefore, they are receiving increasing attention from many medicinal chemistry researchers. The 
quinoxaline ring has been described as a bioisoster of quinolein, naphthalene and some other 
heterocycles which are the base of many antimalarial, antibacterial or antitumor agents (such as 
quinine, mefloquine, isoniazid, pyrazinamide or tirapazamine) [1]. 
The oxidation of both nitrogens of this heterocyclic system, carried out in order to obtain 
quinoxaline 1,4-di-N-oxide (QdO) derivatives, increases the number of biological properties [2]. It has 
been reported that QdO derivatives actually improve the biological results shown by their reduced 
analogues and are endowed with antiviral, anticancer [3,4], anticandidal [5,6], antibacterial [7-11], and 
antiprotozoal activities [12,13]. In fact, since the 1940s, QdOs were known as potent antibacterial agents 
and subtherapeutic levels have been used as animal growth promoters in feed additives [11,14,15]. 
Taking into account the fact that QdOs are receiving growing attention in the field of medicinal 
chemistry, it would be interesting to study the physicochemical properties of this family of 
compounds. The study of absorption, distribution, metabolism and excretion should be considered in 
the first stages of compounds development as this information could be of great help when identifying 
new candidates or optimizing structures [16-19]. The main properties for studying ADME in biological 
systems are solubility, lipophilicity, stability, and acid-base character. Lipid solubility is one of the 
most important determinants of the pharmacokinetic characteristics of a drug and many properties, 
such as absorption, penetration or elimination are related to lipophilicity. 
The logarithm of n-octanol/water partition coefficient (log Po/w) is the most frequently used 
parameter for measuring as it has been shown that this partition system is a good model for many 
biological processes [16,17,20-22]. In fact, log Po/w is also used as one of the standard properties 
identified by Lipinski in the “rule of 5” for drug-like molecules [23,24]. 
Measurement of this parameter is always recommended and many methods have been developed 
for this purpose. The classical shake-flask method is time-consuming. Its use is limited in the log Po/w 
range between -2 and 4, and it is impossible to use with surface-active materials [25]. For these 
reasons, many chromatographic methods have successfully been used to assess lipophilicity of organic 
compounds. HPLC provides an easy, reliable and accurate way to determine the partition properties of 
compounds based on their chromatographic retention times [16,17,26,27]. On the other hand, since the 
1970s, several methods have been proposed for log P computation. These methods could be divided 
into two groups: property-based methods and additive methods. The former group computes log P as a 
function of molecular properties such as molecular surfaces, volumes, partial charges or 
HOMO/LUMO energies, including topological indices as descriptors [28,29]. Additive methods firstly 
introduced by Hansch and co-workers [30-32], use basic structural building blocks as descriptors. They 
calculate the value of a molecule by summing up the contributions from all the blocks of the structure 
and considering some correction factors [26,33-35]. 
In this paper the viability of the RP-HPLC and the shake-flask methods to measure the partition 
coefficients of QdO is studied. Moreover, the capability of different predictive methods to properly 
parametrize the N-oxide function is evaluated. 
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2. Results and Discussion 
2.1. Experimental log Po/w: Shake-Flask vs. RP-HPLC Method 
The lipophilicity of a drug is related to its ability to cross cell membranes by means of passive 
diffusion. This property is usually expressed by the logarithm of the n-octanol/water partition 
coefficient, log Po/w. The log Po/w reflects the relative solubility of the drug in n-octanol (a model of the 
lipid bilayer of a cell membrane) and water (the fluid inside and outside cells). Traditionally, log Po/w 
values are measured using the “shake-flask” with the n-octanol and water partition system. 
The photochemical instability of QdO is well-known and many studies have been reported [36-38]. 
It has been observed that the absorption spectrum of neutral QdO solutions change quickly due to 
exposure to sunlight. For these reasons, solutions of QdO must be kept protected from light and used 
as soon as prepared. With the aim of studying the suitability of the shake-flask method, four 
compounds (10, 14, 22 and 26) were selected and many attempts to measure the log Po/w were 
performed using the classical shake-flask method. Thus, it was verified that the classical “shake-flask” 
method is not suitable for the measurement of log Po/w values of QdO derivatives. In fact, these 
compounds have very low solubility in water and, above all, some of them degrade in solution (see 
supporting information for details) and create emulsions during the partition procedure. 
For these reasons, a RP-HPLC method was used for the determination of log Po/w values of QdO 
derivatives. The RP-HPLC method used (see Experimental section) is applicable to the QdO 
derivatives because it is performed at pH = 7.4 and quinoxalines di-N-oxide derivatives are more stable 
in neutral solutions than working at extreme pH values. Moreover, the period of time in which the 
compounds are in contact with the mobile phase is not long enough for the quinoxalines to degrade as 
was observed when studying the corresponding chromatograms (see supporting information for details). 
2.1.1. Correlation between log Po/w and log k’0 
In this study nine compounds (1–9) have been selected as reference compounds from the 
Recommended Reference Compounds list published by the OECD [39]. The chosen compounds allow 
building a model covering a fairly wide range of log Po/w values (i.e., from ca. 0 to 4.5). The retention 
times of these reference compounds have been measured and expressed as log k’0. The log k’ values 
have been extrapolated to 0% methanol in order to determine the capacity factors represented as log 
k’0. To predict the log Po/w values using the log k’0 values, the least square regression was employed to 
generate Equation (1):  
log P = 0.2759 + 0.9962 log k (1)
R2 = 0.999; RMSE = 0.111; n: 9. 
The cross-validation statistical parameters determined with the Leave One Out procedure were the 
following: 
R2LOO = 0.987; RMSELOO = 0.140  
The detailed results of the LOO test are presented in Table 1. 
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Table 1. log Po/w, log k’0 and related RP-HPLC log Po/w values for the reference compounds. 
Name Code log Po/wa log k’0 
RP-HPLC 
log k’ 
LOO-predicted 
RP-HPLC  
log Po/w 
2-Butanone 1 0.3 −0.06 0.21 0.15 
Aniline 2 0.9 0.67 0.94 0.96 
Acetanilide 3 1.0 0.88 1.15 1.19 
Acetophenone 4 1.7 1.27 1.54 1.52 
Benzene 5 2.1 1.87 2.14 2.14 
Chlorobenzene 6 2.8 2.62 2.89 2.90 
Bromobenzene 7 3.0 2.84 3.10 3.12 
Naphthalene 8 3.6 3.15 3.42 3.36 
Benzyl benzoate 9 4.0 3.74 4.01 4.01 
a Reference log Po/w values taken from OECD Guidelines. 
Taking into account these values, it can be said that Equation (1) can be used to predict the log Po/w 
of QdO derivatives using the log k’0 values. 
2.1.2. log Po/w of Quinoxalines di-N-Oxide 
Retention times of QdO 10–29 were measured and the capacity factors (log k’) were calculated in 
varying proportions of methanol from 70% to 40%. The capacity factors were extrapolated to 0% 
methanol as in the case of the reference compounds (Table 2). The related log Po/w values were 
determined using Equation 6 and are also reported in Table 2. 
Table 2. Capacity factors and related RP-HPLC log Po/w for QdO. 
 
Capacity factors RP-HPLC 
log Po/w 
R R7/R6 Comp. log k’70 log k’60 log k’50 log k’40 log k’0 
C6H5-CH2 
H/H 10 −0.64 −0.34 −0.05 0.28 1.49 1.76 
CH3/H 11 −0.56 −0.24 0.07 0.35 1.58 1.85 
Cl/H 12 −0.36 −0.05 0.30 0.65 1.98 2.25 
Cl/Cl 13 −0.11 0.27 0.66 0.98 2.46 2.72 
2-
phenylethyl 
H/H 14 −0.58 −0.26 0.05 0.36 1.61 1.88 
CH3/H 15 −0.45 −0.13 0.21 0.47 1.73 2.00 
Cl/H 16 −0.37 0.00 0.36 0.69 2.11 2.38 
Cl/Cl 17 −0.06 0.34 0.74 1.07 2.60 2.87 
p-BrC6H4-
CH2 
H/H 18 −0.24 0.11 0.48 0.85 2.30 2.57 
CH3/H 19 −0.16 0.21 0.60 0.94 2.43 2.69 
Cl/H 20 0.02 0.42 0.84 1.22 2.83 3.09 
Cl/Cl 21 0.19 0.65 1.15 1.60 3.51 3.78 
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Table 2. Cont. 
 
Capacity factors RP-HPLC 
log Po/w 
R R7/R6 Comp. log k’70 log k’60 log k’50 log k’40 log k’0 
p-CH3C6H4-
CH2 
H/H 22 −0.44 −0.10 0.25 0.62 2.02 2.29 
CH3/H 23 −0.36 −0.01 0.34 0.66 2.02 2.29 
Cl/H 24 −0.25 0.15 0.54 0.93 2.51 2.77 
Cl/Cl 25 0.14 0.54 0.93 1.33 2.91 3.18 
2,2-
diphenylethyl 
H/H 26 −0.33 0.14 0.62 1.06 2.92 3.18 
CH3/H 27 −0.12 0.33 0.80 1.21 3.02 3.28 
Cl/H 28 −0.13 0.38 0.91 1.38 3.42 3.69 
Cl/Cl 29 0.25 0.76 1.31 1.78 3.86 4.12 
Examination of the data indicates the influence of the quinoxaline structure on the log Po/w values. 
As expected, the log Po/w values of all the QdO derivatives are positive in a range between 1.5 and 4.5. 
The 20 compounds can be divided into five different series based on structure. Within each series of 
analogues, the insertion of a methyl group resulted in a soft increase of the log Po/w value, and 
replacing the hydrogen atom with one or two chloro groups supposed an increase of 0.5 or 1.0 unit, 
respectively. Increasing the aliphatic chain between the amide group and the aromatic system resulted 
in an increase of the log Po/w values as can be observed comparing derivatives 10, 11, 12, 13 versus 14, 
15, 16, 17. The p-bromo substituent (compounds 18–21) increases the lipophilicity of the molecules. 
Finally, looking at the values of compounds 26, 27, 28 and 29, it can be observed that these 
compounds, which contain a diphenyl substituent on the amide chain, presented the highest log Po/w 
values of all the QdO derivatives. 
Therefore, the results suggest that the HPLC analysis is a suitable method for determining the log 
Po/w for quinoxaline derivatives instead of classical methods which are too slow, labor intensive and 
expensive. In particular, the RP-HPLC method for the QdO derivatives allows avoiding the problems 
associated with the classical shake-flask method, impossible to use with this kind of compounds. 
2.2. Calculated log Po/w 
All of the QdO were subjected to the ALOGPS online module. Seven values were obtained for each 
compound using different computational methods included in this module. The predicted log Po/w data 
are reported in Table 3. RMSE was calculated for each computational method in order to judge which 
method best suits experimental RP-HPLC. 
The RMSE calculated from experimental and estimated log Po/w values ranged between 0.36 and 
3.52 for XLOGP3 and MLOGP, respectively. From these data, XLOGP3 can be considered as the best 
approach to estimate log Po/w for the QdO. 
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Table 3. Calculated log Po/w for quinoxaline derivatives and related RMSE. 
Comp. RP-HPLC log Po/w 
Calculated log Po/w 
ALOGPs miLOGP ALOGP MLOGP LogKOW XLOGP2 XLOGP3
10 1.76 0.43 −0.48 1.11 −1.71 0.55 5.03 1.28 
11 1.85 0.50 −0.05 1.60 −1.47 1.10 5.46 1.64 
12 2.25 1.03 0.18 1.77 −1.20 1.20 5.65 1.90 
13 2.72 1.72 0.78 2.44 −0.70 1.84 6.27 2.53 
14 1.88 0.63 −0.07 1.43 −1.47 1.04 5.18 1.74 
15 2.00 0.80 0.35 1.92 −1.24 1.59 5.62 2.10 
16 2.38 1.25 0.58 2.09 −0.97 1.69 5.80 2.37 
17 2.87 2.03 1.19 2.76 −0.47 2.33 6.43 2.99 
18 2.57 1.14 0.33 1.86 −1.08 1.44 5.82 1.97 
19 2.69 1.29 0.76 2.34 −0.85 1.99 6.26 2.33 
20 3.09 1.82 0.99 2.52 −0.59 2.09 6.44 2.60 
21 3.78 2.74 1.59 3.19 −0.09 2.73 7.07 3.22 
22 2.29 0.56 −0.03 1.60 −1.47 1.10 5.46 1.64 
23 2.29 0.75 0.40 2.08 −1.24 1.65 5.90 2.01 
24 2.77 1.22 0.63 2.26 −0.97 1.74 6.08 2.27 
25 3.18 2.31 1.07 2.71 −0.36 2.16 6.71 2.90 
26 3.18 1.78 1.31 2.78 −0.35 2.16 6.67 3.19 
27 3.28 1.98 1.74 3.27 −0.14 2.71 7.11 3.56 
28 3.69 2.36 1.97 3.45 0.12 2.81 7.29 3.82 
29 4.12 3.19 2.57 4.11 0.60 3.45 7.92 4.45 
RMSE  1.28 1.96 0.43 3.52 0.89 3.47 0.36 
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Nevertheless, and in an attempt to improve the predictive capacity of the ALOGPS, the LIBRARY 
mode was used, and experimental log Po/w data of compounds 10–13 were used to generate the library 
that was taken into consideration for recalculating the log Po/w of the rest of QdO (Table 4). 
Table 4. Calculated log Po/w for quinoxaline derivatives using ALOGPS with and without 
LIBRARY mode. 
Comp. RP-HPLC log Po/w 
ALOGPs ALOGPs LIBRARY 
14 1.88 0.63 1.93 
15 2.38 1.25 2.43 
16 2.00 0.80 2.08 
17 2.87 2.03 3.04 
18 2.57 1.14 2.40 
19 3.09 1.82 2.92 
20 2.69 1.29 2.54 
21 3.78 2.74 3.54 
22 2.29 0.56 1.90 
23 2.77 1.22 2.41 
24 2.29 0.75 2.06 
25 3.18 2.31 3.19 
26 3.18 1.78 3.18 
27 3.69 2.36 3.67 
28 3.28 1.98 3.33 
29 4.12 3.19 4.32 
RMSE  1.29 0.19 
The examination of the data reveals that ALOGPS LIBRARY mode presents a RMSE of 0.19, 
making it the best approach for predicting the partition coefficients of QdOs. 
In Silico Screening of the QSAR Relationship 
The anti-tuberculosis activity of the studied compounds has been previously reported [40,41].  
In vitro evaluation of the anti-tuberculosis activity has been carried out within the Tuberculosis 
Antimicrobial Acquisition & Coordinating Facility (TAACF) screening program for the discovery of 
novel drugs for the treatment of tuberculosis. The compounds were tested against Mycobacterium 
tuberculosis H37Rv (ATCC 27294) in BACTEC 12B medium using the Microplate Alamar Blue 
Assay (MABA). Compounds showing an IC90 value of ≤10 µg/mL were considered “Active” for 
antitubercular activity and considered for the VERO cell cytotoxicity assay. Cytotoxicity is determined 
as the CC50 using a curve fitting program. Ultimately, the CC50 is divided by the IC90 to calculate a SI 
(Selectivity Index) value. SI values of ≥10 are considered “Active”. 
Since log Po/w is an important ADME parameter, a correlation with the anti-tuberculosis activity of 
compounds was looked for. However, it was verified that there is not a strong relationship (R2 < 0.2) 
between log Po/w and activity, expressed as log(1/IC50) or log(1/IC90). In spite of this, it seems that a 
low value of log Po/w could be related with better values of anti-tuberculosis activity. 
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This fact could be explained as a consequence of the structure of the M. tuberculosis envelope 
structure. Porin presented in the membrane control the diffusion of small hydrophilic molecules; and, 
therefore, M. tuberculosis is more permeable to hydrophilic drugs such as INH, PZA, EMB or 
gatifloxacin that present a log P of −0.71, −0.71, −0.12 and −0.23, respectively (ALOGPS, [42]) In this 
sense, lipophilic molecules should be able to easily cross the lipid bilayer; however, the bilayer’s 
uncommon thickness and the presence of the mycolic acids seem to dicrease the permeability to 
lipophilic drugs. Nevertheless, it has been observed that the more lipophilic the agents are, the more 
active they usually are against M. tuberculosis, as for instance, PAS, RIF or rifapentine presenting log 
P values of 0.62, 3.85 and 4.83, respectively (ALOGPS). This fact suggests that there must be an 
specific pathway for lipophilic drug transport [43]. 
Recent studies have focused on the influence of physicochemical properties of antibacterial drugs 
and they have concluded that it is not possible to establish a strong relationship between these 
properties and the anti-tuberculosis activity. In this sense, it seems that much work is needed in order 
to understand M. tuberculosis and its metabolism. At this moment, recent reviews affirm that 
antibacterial drugs constitute an special physicochemical space completely different from the space 
covered by drugs in many other therapeutic areas [44]. 
On the other hand, in the previous paper a good relationship was found between redox peak 
potential Epc,1 and activity [45]. In that case, however, the correlation was found within an almost 
homogeneous series of molecules. Here a more heterogeneous set of compounds has been studied. For 
molecules 11–24, 26–29 there is not a strong relationship (R2 < 0.2) between peak potential and 
activity. However, it is evident that the compounds roughly align (according to the R substituent) or 
group themselves (according to the R6 and R7 substituents) in homologous series. This behaviour 
justifies the previously found relationship for a small and almost uniform set of molecules. 
The above said results point out that log Po/w and Epc,1, although important parameters, cannot 
explain alone the observed activity. When considering simultaneously the effect of both factors, a  
two-variable model was built to predict activity, resulting in a better fitting ability (R2 ≅ 0.53). Some 
other variable is probably needed to improve the model.  
In order to enlarge the set of possible variables, the structures of compounds 10–29 were optimised 
with the MOE (Molecular Operating Environment) software using a MMFF force field [46]. From the 
optimised structures 333 molecular descriptors were calculated. This set of parameters was reduced to 
269 excluding variables with constant values. A multiple linear regression (MLR) procedure with a 
stepwise forward selection of the variables was applied to the whole set of variables (269 from MOE 
plus the experimental log Po/w and redox peak potential). This resulted in a two-variable model  
(R2 ≅ 0.8) both for log(1/IC50) and log(1/IC90). 
One selected descriptor (vsurf_HB6) belongs to the “Surface Area, Volume and Shape Descriptors” 
family and is related to the H-bond donor capacity. The other descriptor (SlogP_VSA4) belongs to the 
“Subdivided Surface Areas” group and is related to an approximate accessible van der Waals surface 
area calculation for each atom, along with the contribution to log Po/w (as calculated in MOE) for each 
atom (see Supporting Information). 
The addition of both experimental log Po/w and Epc,1 to the previously selected two descriptors 
allowed us to build a four-variable model with R2 = 0.85 for log(1/IC50) and R2 = 0.84 for log(1/IC90). 
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In conclusion, the reported statistical analysis confirms the importance of the reduction peak 
potential Epc,1 in the definition of the cytotoxic activity. This reduction process has been demonstrated 
to be consistent with reduction of the N-oxide functionality to form a reactive radical anion, which 
could lead further to superoxide ion or other toxic oxy radical species responsible for the biological 
activity [45]. However, in order to obtain a more general QSAR relationship, three other descriptor 
should be considered. Although the relatively small number of compounds considered, with respect to 
the large set of descriptors, limited the fitting ability of the model (R2 ≥ 0.84), the lipophilicity, the  
H-bond donor capacity and a descriptor related to the molecular dimensions were found to be involved 
in the modulation of the final biological activity. In particular, on the basis of the regression 
coefficient, the redox properties (Epc,1) correlate positively with both log(1/IC50) and log(1/IC90); this 
means that an easy reduction increases the activity. On the contrary, the lipophilicity and shape 
descriptors affect the activity negatively. 
3. Experimental Section  
3.1. Chemical Synthesis 
The synthesis of the quinoxaline 1,4-di-N-oxide derivatives was carried out by a variation of the 
Beirut reaction [36,47-51], where the appropriate benzofuroxan (BFX) reacts with the corresponding  
β-ketoamide in the presence of calcium chloride and ethanolamine as catalysts (Scheme 1). The 
methods for the synthesis of quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives and the structure 
characterization were reported elsewhere [40,41]. 
Scheme 1. General synthetic scheme. 
 
Reagents and conditions: (I) N,N-DMF, NaClO, rt.; (II) methanol, 0 °C, N2 atm.; 
(III) methanol, CaCl2, ethanolamine. 
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3.2. RP-HPLC Method 
The RP-HPLC methods of Minick [52] and Lombardo [53] were considered for estimating the  
n-octanol/water partition coefficients (log Po/w) of QdO. The inorganic salts and the reference 
compounds were, at least, of analytical grade (Sigma Aldrich and Fluka) and used without further 
purification. HPLC-grade methanol, n-octanol (Sigma-Aldrich) and bi-distilled water were used to 
prepare the mobile phase. The retention times (tR) were measured using a Waters 2695 Separation 
Module system and a Waters 2487 Dual λ Absorbance Detector with Empower Pro Software. 
The Supelcosil LC-ABZ column (5 μm, 15 cm × 4.6 mm) [18,52-54] was selected to substitute the 
organic phase of the shake-flask method because it has been reported that this column affords a 
reasonable correlation model for a great variety of compounds [18,22,49,55]. The mobile phase 
consisted of 20 mM 3-morpholinopropanesulfonic acid (MOPS) buffer (pH 7.4) and methanol in 
varying proportions, from 70 to 40%. n-Octanol (0.25%) was added to methanol, and n-octanol-
saturated water was used to prepare the buffer [41]. The other chromatographic conditions were: flow 
1.0 mL/min−1; isocratic elution, UV-visible detector set at the wavelength with maximum absorbance 
(260 and 210 nm). The test solutions were 0.3 mM in the desired compound. All the experiments were 
performed at 25 ± 2 °C at least twice. 
The tR of each QdO derivative 10–29 was measured at different proportions of methanol (from 70 to 
40%) and injections of pure methanol were used to determine the column dead-time (t0). The capacity 
factors were calculated according to Equation (2): 
log k’ = log[(tR − t0) / t0] (2) 
Starting from these results, the extrapolation to 0% methanol for each compound was calculated and 
the capacity factors were used to predict the corresponding log Po/w. 
The capacity factors of compounds 1–9, with known log Po/w [16,20,39] and accepted as reference 
compounds by the OECD [39], were used to create a calibration curve [Equation (3)]: 
log Po/w = a log k’0 + b (3) 
The common coefficient of determination R2 was used to evaluate the fitting ability of the model. 
Another measurement for defining the accuracy of the proposed model is the RMSE (Root Mean 
Squared Error), which summarizes the overall error of the model [Equation (4)]: 
( )
n
yy
RMSE
n
i ii∑ = −= 1 2ˆ  (4) 
where ŷi is the log Po/w value calculated by Equation (2), yi is the reference value and n is the number 
of reference compounds used to create the curve. 
3.3. Cross-Validation of the RP-HPLC Method 
In order to judge if the experimentally measured log k’0 can be used to predict the log Po/w value, a 
calibration curve was created with the capacity factors of the reference compounds and a linear 
regression equation between the log Po/w and log k’0 was determined. 
Molecules 2011, 16                   
 
 
7903
The robustness of the model and its predictivity were evaluated by the leave-one-out (LOO)  
cross-validation procedure [28,56]. According to this procedure, the log Po/w value of each compound 
in the reference data set is predicted by the equations derived from all the other compounds except the 
predicted one. At the end of this procedure two values are available for each reference compound, the 
reference shake-flask log Po/w value (yi) and the predicted one (ŷi). With these data, two statistical 
parameters (R2LOO, RMSELOO) were calculated to indicate the predictivity of the model. The regression 
coefficient (R2LOO) is defined by Equation (5): 
( )
( )2
1
1
2
2
ˆ
1 ∑
∑
=
=
−
−−=
n
i ii
n
i ii
LOO
yy
yy
R  (5) 
where iy  is the mean of the reference shake-flask log Po/w value and n is the number of reference 
compounds. A high value of R2LOO indicates a good predictive ability of the model. The root mean 
squared error in prediction (RMSELOO) is calculated with Equation (6): 
( )
n
yy
RMSE
n
i ii
LOO
∑ = −= 1 2ˆ   (6) 
3.4. log Po/w Predictive Approaches 
All of the synthesized QdO were subjected to the ALOGPS module with the aim of comparing 
experimental log Po/w values and predicted data. The ALOGPS method is part of the ALOGPS 2.1 
program and provides interactive on-line predictions of log Po/w and aqueous solubility. log Po/w values 
can be obtained from different computation methods: ALOGPS 2.1 includes, among other calculation 
programs, ALOGPs, miLogP, ALOGP, MLOGP, KOWWIN, XLOGP2 and XLOGP3 [42]. 
The lipophilicity calculations within ALOGPS 2.1 are based on the associative neural network 
approach and an efficient partition algorithm. ALOGPs was developed with 12,908 molecules from the 
PHYSPROP database using 75 E-state indices. 64 neural networks were trained using 50% of 
molecules selected by chance from the whole set. The log Po/w prediction accuracy is RMSE = 0.35 
and standard mean error s = 0.26 [33]. 
This program also provides a possibility to include new data into the memory of neural nets without 
retraining the neural networks themselves in the so-called LIBRARY mode. The LIBRARY 
dramatically improves prediction of the ALOGPS program for the log Po/w prediction using in-house 
data sets [21,33,35]. The LogKow (Kow-WIN) program estimates the log Po/w of organic compounds 
and drugs using an atom/fragment contribution method developed at Syracuse Research Corporation [57]. 
The miLogP is calculated by the methodology developed by Molinspiration as a sum of fragment-
based contributions and correction factors. This method for log Po/w prediction is based on group 
contributions which have been obtained by fitting calculated log Po/w with experimental log Po/w for a 
training set of more than twelve thousand, mostly drug-like molecules. Molinspiration methodology [58] 
for log Po/w calculation is very robust and capable of processing practically all organic and most 
organometallic molecules XLOGP2 gives log Po/w values by summing the contributions of component 
atoms and correction factors. Altogether 90 atom types are used to classify carbon, nitrogen, oxygen, 
sulfur, phosphorus and halogen atoms, and 10 correction factors are used for some special 
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substructures. The contributions of each atom type and correction factor are derived by multivariate 
regression analysis of 1853 organic compounds with known experimental log Po/w  
values [34]. The additive model implemented in XLOGP3 uses a total of 87 atom/group types and two 
correction factors as descriptors. It is calibrated on a training set of 8,199 organic compounds with 
reliable log Po/w data through a multivariate linear regression analysis [26]. ALOGP, also known as 
“Ghose-Crippen octanol-water partition coefficient”, is a log Po/w calculated with the Ghose-Crippen 
contribution method based on hydrophobic atomic constants measuring the lipophilic contributions of 
atoms in the molecule, each described by its neighbouring atoms [59]. MLOGP, also known  
as “Moriguchi octanol-water partition coefficient”, expresses log Po/w in terms of 13 structural  
parameters. 
4. Conclusions 
In this study the RP-HPLC retention times of 20 QdO derivatives were measured and it was found 
that highly accurate log Po/w values can be predicted from the experimental log k’0 by using the linear 
regression equation relating log Po/w and log k’0 (Equation 1). Consequently, the results suggest that the 
determination of log Po/w for QdO can be successfully carried out by measuring the capacity factors 
based on the simple RP-HPLC method. This method allows us to avoid the experimental problems 
presented by the classical shake-flask method when trying to measure the partition coefficients of QdO 
derivatives that present low stability in aqueous solution and create emulsions during partitioning. 
After a comparison among different methods for the calculation of log Po/w, in cases where no 
experimental data is available, XLOGP3 is proposed as the best program to calculate the log Po/w 
values for the QdO presented in this work (RMSE = 0.36). On the other hand, the ALOGPS 
LIBRARY method, implemented with the experimental data, predicts log Po/w values that match the 
experimental ones with the lowest RMSE (0.19). 
Finally, a preliminary statistical analysis confirms the importance of the reduction peak potential 
Epc,1 in the definition of the cytotoxic activity of QdO. Moreover, the lipophilicity, the H-bond donor 
capacity and a descriptor related to the molecular dimension were found to also be involved in the 
modulation of the final biological activity. 
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